Solventum (NYSE:SOLV) & Acutus Medical (NASDAQ:AFIB) Head to Head Analysis

Acutus Medical (NASDAQ:AFIB) and Solventum (NYSE:SOLV) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, profitability, earnings, dividends and valuation.

Profitability

This table compares Acutus Medical and Solventum’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Acutus Medical	-272.74%	-311.64%	-11.57%
Solventum	N/A	N/A	N/A

Analyst Ratings

This is a breakdown of recent ratings and price targets for Acutus Medical and Solventum, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Acutus Medical	0	0	0	0	0.00
Solventum	1	7	2	0	2.10

Solventum has a consensus target price of $80.29, indicating a potential upside of 10.62%. Given Solventum’s stronger consensus rating and higher possible upside, analysts clearly believe Solventum is more favorable than Acutus Medical.

Earnings and Valuation

This table compares Acutus Medical and Solventum”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Acutus Medical	$7.16 million	0.04	-$81.66 million	N/A	N/A
Solventum	$8.31 billion	1.51	$373.71 million	$2.16	33.60

Solventum has higher revenue and earnings than Acutus Medical.

Insider and Institutional Ownership

56.9% of Acutus Medical shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by insiders. Comparatively, 0.1% of Solventum shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Solventum beats Acutus Medical on 9 of the 11 factors compared between the two stocks.

About Acutus Medical

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.